Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 172 clinical trials
featured
  • 62 views
  • 23 Nov, 2020
  • 24 locations
featured
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients with Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients with Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based

  • 1940 views
  • 25 Mar, 2021
  • 107 locations
featured
A Randomized Phase 3 Study of Sitravatinib in Combination with Nivolumab Versus Docetaxel in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with Disease Progression On or After Platinum-Based Chemotherapy and Checkpoint Inhibitor Therapy (SAPPHIRE)

docetaxel in patients with advanced non-squamous NSCLC who have previously experienced radiographic disease progression on or after treatment with platinum-based chemotherapy in combination with CIT.

cancer
lung carcinoma
platinum-based chemotherapy
nivolumab
experimental drug
  • 199 views
  • 05 Mar, 2021
  • 142 locations
featured
A Randomized, Double Blind, Phase 3 Study of Platinum-Based Chemotherapy With or Without INCMGA00012 in First-Line Metastatic Squamous and Nonsquamous Non–Small Cell Lung Cancer.

The purpose of this study is to assess the efficacy and safety of platinum-based chemotherapy with or without INCMGA00012 in participants with metastatic squamous and nonsquamous non–small

cancer
lung carcinoma
platinum-based chemotherapy
cancer chemotherapy
measurable disease
  • 12 views
  • 14 Dec, 2020
  • 1 location
featured
  • 326 views
  • 08 Nov, 2020
  • 27 locations
featured
A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma (516-003)

following: Whether or not patients were previously treated with or were ineligible for platinum-based chemotherapy  Whether or not patients were previously treated with a

tumor cells
cancer
advanced urothelial cancer
platinum-based chemotherapy
nivolumab
  • 80 views
  • 05 Mar, 2021
  • 31 locations
Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

The purpose of this study is to evaluate if the addition of GSK3359609 to pembrolizumab in combination with 5FU-platinum based chemotherapy improves the efficacy of the pembrolizumab combination

squamous cell carcinoma
carboplatin
squamous cell carcinoma of head and neck
oropharyngeal
measurable disease
  • 0 views
  • 11 Apr, 2021
  • 92 locations
Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab Followed by Maintenance Durvalumab Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients.

This is a Phase III randomised, double-blind, multi-centre study to evaluate the efficacy and safety of durvalumab in combination with standard of care platinum based chemotherapy and

  • 84 views
  • 11 Apr, 2021
  • 284 locations
SAR408701 Versus Docetaxel in Previously Treated Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small Cell Lung Cancer Patients

-of-care platinum-based chemotherapy and an immune checkpoint inhibitor (ICI). The primary objective is to determine whether SAR408701 improves the overall survival (OS) when compared with

cancer
platinum-based chemotherapy
squamous non-small cell lung cancer
measurable disease
docetaxel
  • 23 views
  • 11 Apr, 2021
  • 217 locations
Niraparib + Ipilimumab or Nivolumab in Progression Free Pancreatic Adenocarcinoma After Platinum-Based Chemotherapy

The main purpose of this study is to look at the effectiveness, safety, and anti-tumor activity (preventing growth of the tumor) of the drugs Niraparib with either Ipilimumab or Nivolumab on patients and their pancreatic cancer.

cancer
oxaliplatin
metastatic pancreatic cancer
nivolumab
metastasis
  • 23 views
  • 15 Feb, 2021
  • 1 location